Coeptis Therapeutics is merging with Z Squared to pivot towards Dogecoin mining, aiming to become the largest publicly traded Dogecoin miner.
Following the announcement, Coeptis shares plummeted nearly 40% to 7.53 USD. Despite this drop, they are still up 37% year-to-date, but down over 96% from all-time highs.
The company plans to maintain its biopharmaceutical operations and is exploring additional cryptocurrency initiatives, indicating an expansive strategy beyond Dogecoin.
Leave a Reply